Genmab Stock Nasdaq Copenhagen
Stocks
DK0010272202
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,556.00 DKK | +27.86% |
|
+4.14% | +14.24% |
| Market Cap | 95.53B 14.83B 12.78B 11.77B 11.05B 20.74B 1,402B 20.96B 139B 54.17B 687B 55.65B 54.46B 2,379B | P/E Ratio 2026 * |
21.1x | P/E Ratio 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 115B 17.85B 15.39B 14.17B 13.3B 24.97B 1,688B 25.24B 167B 65.22B 827B 67B 65.58B 2,864B | EV / Sales 2026 * |
4.16x | EV / Sales 2027 * | 3.33x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab
| 1 day | -0.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +27.86% | +4.14% | - | - | 15.19B | |
| -0.71% | -0.29% | +56.45% | +107.18% | 54.92B | |
| -1.22% | +2.25% | +43.78% | +38.45% | 44.31B | |
| -0.10% | +5.05% | -14.54% | -19.26% | 22.96B | |
| -1.37% | -3.29% | -5.72% | +378.90% | 21.12B | |
| -2.91% | -1.18% | +7.21% | -36.53% | 16.31B | |
| -1.09% | -1.08% | +25.56% | +174.59% | 13.32B | |
| +1.48% | +11.36% | +22.59% | - | 12.48B | |
| +4.10% | +7.02% | +104.41% | +226.33% | 11.21B | |
| +1.11% | +5.58% | +76.63% | +106.28% | 11.52B | |
| Average | -0.13% | +3.56% | +35.15% | +121.99% | 23.13B | |
| Weighted average by Cap. | -0.54% | +2.51% | +35.45% | +105.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.64B 4.29B 3.7B 3.41B 3.2B 6B 406B 6.07B 40.24B 15.68B 199B 16.1B 15.76B 688B | 32.41B 5.03B 4.34B 3.99B 3.75B 7.04B 476B 7.11B 47.18B 18.38B 233B 18.88B 18.48B 807B |
| Net income | 4.71B 731M 630M 580M 545M 1.02B 69.16B 1.03B 6.86B 2.67B 33.87B 2.75B 2.69B 117B | 7.02B 1.09B 939M 865M 812M 1.52B 103B 1.54B 10.22B 3.98B 50.45B 4.09B 4B 175B |
| Net Debt | 19.49B 3.02B 2.61B 2.4B 2.25B 4.23B 286B 4.28B 28.37B 11.05B 140B 11.35B 11.11B 485B | 12.47B 1.94B 1.67B 1.54B 1.44B 2.71B 183B 2.74B 18.15B 7.07B 89.62B 7.26B 7.11B 311B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
